M.Ismail MD FAASLD
@mismail_md
Followers
216
Following
1K
Media
184
Statuses
2K
Joined June 2011
🌍 Excited to be part of this international collaboration! Our new paper: “Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD” Published in Clinical Gastroenterology & Hepatology 🔗 Free access until Oct 18,
0
3
4
🌟 Special GI Event – Al Khobar 🌟 The Saudi Gastroenterology Association (@SGA_KSA) and GIT/Liver Club – Al Khobar are thrilled to host an exceptional evening of knowledge and inspiration with one of the world’s leading experts in Gastroenterology! 🗓 Date: Wednesday, August
1
7
22
Explore our #hepatitis research this #WorldHepatitisDay! Check out our curated hepatitis elimination article collection highlighting breakthroughs in treatment, prevention, & public health. 📷 Explore the leading research now: https://t.co/jjkPAv7ItD
#LiverHealth #AASLD
0
4
7
ماهي طرق انتقال التهاب الكبد الفيروسي؟ وكيف تحمي نفسك؟ 🛡️ #اليوم_العالمي_لالتهاب_الكبد_الفيروسي #مستشفى_الملك_فهد_الجامعي
0
12
11
#اليوم_العالمي_لالتهاب_الكبد_الفيروسي خطوتك الأولى للحماية تبدأ بالفحص المبكر 🩺💡 التهاب الكبد مرض قد لا تظهر له أعراض، لكنه قابل للكشف والعلاج. لا تنتظر… الوقاية تبدأ بالتطعيم واتباع ممارسات صحية سليمة ✅
0
9
10
#اليوم_العالمي_لالتهاب_الكبد_الفيروسي د. اماني كوشك، طبيب زمالة جهاز هضمي وكبد و مناظير و شرح عن التهاب الكبد (أ). #مستشفى_الملك_فهد_الجامعي
5
17
18
#اليوم_العالمي_لالتهاب_الكبد_الفيروسي د. سليمان العمري، طبيب زمالة جهاز هضمي وكبد و مناظير و شرح عن التهاب الكبد (ج). #مستشفى_الملك_فهد_الجامعي
1
13
15
#اليوم_العالمي_لالتهاب_الكبد_الفيروسي د. عبد الله العتيبي، استشاري جهاز هضمي وكبد و مناظير و حديث عن التهاب الكبد (ب). #مستشفى_الملك_فهد_الجامعي
0
14
18
🚨 Liver Biopsy remains a 🔑 tool in our 🧰 , so #GIHepFellowshipBootcamp is here to get you ready to understand: 💉Utility of biopsy across conditions❕ 💉Biopsy histologic characteristics❕ 💡The table below is GOLD 🏆 https://t.co/eUOMCGDjdN
1
62
137
NEW ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease Singal & Wong, et al. 📕 https://t.co/YcTCM2C5TD
@singal_ashwani @Robert_J_Wong @JasmohanBajaj @MLongMD
1
35
76
New study Alert🚨: Secondary SBP prophylaxis in cirrhosis is associated with a higher risk of non-SBP infections (UTIs, pneumonia, bacteremia, C. difficile) in two US cohorts. Antibiotic stewardship is critical! #Hepatology #Cirrhosis #LiverTwitter #SBP @ACG_CTG
Unnecessary #antibiotic use: #SBP prophylaxis in #cirrhosis ⬆️not only #SBP but also other infections! Esp #UTIs that share similar🦠 latest from @VAResearch & @Trinetx @ACG_CTG ⤵️ https://t.co/ml8SKOZAYK 50% of US ❌use SBPProph..should we all follow to ⬇️#AMR? @ABsteward
0
0
1
Today, on #InternationalWomensDay, we celebrate the incredible contributions of women in #hepatology. From pioneering research to patient care, their dedication is shaping the future of #liver health. #IWD2025
3
10
22
Check out this outstanding review of #MASLD for Nature Reviews Disease Primers. I am impressed with the 357 references! Dive into the latest insights and research priorities. @DrHuangDQ @VWSWong @RinellaMary @JVLazarus @JeromeBoursier @DrLoomba @DiseasePrimers
2
44
136
Comparison of pharmacological therapies in metabolic dysfunction-associated steatohepatitis for fibrosis regression… https://t.co/bGelfCRn9x
@AASLDtweets @EASLnews @DrHuangDQ
pubmed.ncbi.nlm.nih.gov
This study provides updated rank-order efficacy of MASH pharmacological therapies for fibrosis regression and MASH resolution. These data are helpful to inform practice and clinical trial design.
0
11
35
Data on the bugs that cause SBP is so old UNTIL NOW! Thank you @nadimmahmud Varies with Child Class. Staph is climbing the charts! https://t.co/SqpCsMdqiD
1
27
91
What’s the best way to implement the 2-step clinical care pathway for evaluating MASLD? Is it as effective as VCTE for all patients? Check out this paper in J Hep: https://t.co/kE14CUXC1A. Congrats to @TerryYip12 and the VCTE-Prognosis Study Team! 🎉 #MASLD #ClinicalResearch
2
18
37
🚨 AGA New Guideline Alert Link🚨 ▶️ AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals 👀 https://t.co/73LuSoR7Lt I’ll break down its FIVE recs over next 12 posts 🧵 👇 #AGA #GI #HBV #GITwitter #LiverTwitter
gastrojournal.org
Hepatitis B reactivation (HBVr) can occur due to a variety of immune-modulating exposures, including multiple drug classes and disease states. Antiviral prophylaxis can be effective in mitigating the...
3
51
110
The greatest review written on liver biopsy: indications, interpretation, and its future By Dr Purva Gopal and colleagues in @HepCommJournal Open access https://t.co/llLYkPtpXq
#livertwitter #PathTwitter
5
92
253
Top 2024 Article: Muscle matters: the effects of medically induced weight loss on skeletal muscle. https://t.co/Grk5XMUIPv
2
105
338